Therefore, improving insulin sensitivity not only reduces plasma glucose concentrations in patients with T2DM, but also reduces the risk of cerebrovascular disease independent of the control of blood glucose levels (43, 56). This evidence concerns the gene INS and type 2 diabetes mellitus.